> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Draft Guide on Drug Supplier Verification Systems
- URL: https://www.fdaweb.com/draft-guide-on-drug-supplier-verification-systems/
- Published: 2022-03-10T12:00:00.000Z
- Updated: 2026-09-14T17:36:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151336

*Federal Register* notice: FDA has made available a revised draft guidance entitled “Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs.” The document addresses the verification systems that manufacturers, repackagers, wholesale distributors, and dispensers must have in place to comply with the Federal Food, Drug, and Cosmetic Act. Specifically, it discusses the statutory verification system requirements that include the quarantine and investigation of a product determined to be suspect and the quarantine and disposition of a product determined to be illegitimate. The guidance also addresses the statutory requirement for notification to the agency about a product that has been cleared after a suspect product investigation. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-03-10/pdf/2022-05018.pdf?ref=fdaweb.com).